Search for: "HI TECH PHARMACEUTICALS INC"
Results 121 - 140
of 148
Sorted by Relevance
|
Sort by Date
12 Oct 2007, 12:57 am
ALM Privacy Policy / Contact Us
© 2007 ALM Properties, Inc. [read post]
1 Jun 2010, 8:16 am
He was the lead trial lawyer for Forest Laboratories Inc. in an effort to block Teva Pharmaceutical Industries Ltd. from selling a generic version of the antidepressant Lexapro. [read post]
27 Sep 2009, 2:30 pm
Turn-Key-Tech, LLC, 381 F.3d 1142, 1149 (Fed. [read post]
12 Aug 2016, 4:49 pm
Low tolerance for borrowing in paintings; high tolerance for borrowing in pharmaceuticals. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
17 Oct 2015, 5:29 am
Testimony by Expert Witnesses A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if the testimony satisfies each of the following requirements: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data that reliably support the expert’s… [read post]
26 May 2011, 10:54 am
Novartis Pharmaceuticals Corp., 2010 WL 1463035, at *1 (D.N.J. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
20 Nov 2017, 1:14 pm
Virginia Citizens Consumer Council, Inc., 425 U.S. 748, 763 (1976). [read post]
20 Nov 2017, 1:14 pm
Virginia Citizens Consumer Council, Inc., 425 U.S. 748, 763 (1976). [read post]
24 Apr 2020, 6:58 am
Both the Federal Circuit and the predecessor Court of Claims have deemed reasonable royalty awards to be “the preferred manner” of compensation under section 1498; in Tektronix Inc. v. [read post]
31 May 2020, 4:22 pm
Craig Wright, the Australian computer scientist and businessman who claims to be the inventor of Bitcoin, Satoshi Nakamato lost his appeal against a decision by the High Court to strike out his libel claim on jurisdictional grounds. [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
22 Nov 2008, 2:52 pm
Concurrent Tech Corp., No. 08-2370 (3d Cir. [read post]
5 Jan 2009, 3:15 am
MGS 782 Lex, Inc., No. 07-4480 (2d Cir. [read post]
3 Apr 2009, 3:49 am
WellPoint, Inc. [read post]
15 Dec 2014, 7:25 am
After his earlier post on Hospira v Genentech [on which see also the IPKat earlier note here], Darren provides a catch-up summarizing the large number of comments and the debate that it has generated. [read post]
31 Jan 2010, 5:56 pm
Domains by Proxy, Inc. 2. [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
29 Feb 2012, 8:25 am
Sniderman’s credentials as a researcher and published author, as well as clinician, and his ability to analyze the epidemiological research, as demonstrated in his report. [read post]
